Financial statements Centrum Onkologii Bioinvent
Balance sheet of Centrum Onkologii Bioinvent
Company age:
Age:
13 y. 4 m. 27 d.
Share capital:
Share capital:
50 000 PLN
Balance sheet data of CENTRUM ONKOLOGII BIOINVENT
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 161,00 | 1 483,00 | 1 533,00 | 1 179,00 | 1 410,00 | 1 690,00 |
| A. Fixed assets | 98,00 | 0,00 | 1 415,00 | 852,00 | 432,00 | 632,00 |
| B. Current assets | 1 062,00 | 8,00 | 118,00 | 327,00 | 978,00 | 1 058,00 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 161,00 | 1 483,00 | 1 533,00 | 1 179,00 | 1 410,00 | 1 690,00 |
| A. Equity | 852,00 | 536,00 | 933,00 | 50,00 | 50,00 | 50,00 |
| B. Liabilities and provisions for liabilities | 309,00 | 947,00 | 599,00 | 1 129,00 | 1 360,00 | 1 640,00 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.